Literature DB >> 21447090

The role of WNT10B in physiology and disease.

P Wend1, K Wend, S A Krum, G A Miranda-Carboni.   

Abstract

Wnt10b is a member of the Wnt ligand gene family that encodes for secreted proteins, which activate the ancient and highly conserved Wnt signalling cascade. The Wnt pathway has been shown to be essential for embryonic development, tissue integrity, and stem cell activity, but if deregulated, also causes disease such as cancer. Although the 19 different Wnt ligands found in both human and mouse can activate several branches of the Wnt pathway, WNT10B specifically activates canonical Wnt/β-catenin signalling and thus triggers β-catenin/LEF/TCF-mediated transcriptional programs. In this review, we highlight the unique functions of WNT10B and mechanisms of how WNT10B acts in the immune system, mammary gland, adipose tissue, bone and skin. In these organs, WNT10B has been well established to be involved in signalling networks controlling stemness, pluripotency and cell fate decisions. Deregulation of these processes causes diseases such as breast cancer, obesity and osteoporosis. Compelling evidence suggests that WNT10B is a valuable candidate for the development of therapeutic regimens for human diseases.
© 2011 The Authors. Acta Physiologica © 2011 Scandinavian Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447090     DOI: 10.1111/j.1748-1716.2011.02296.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  30 in total

1.  GSK-3b participates in the regulation of hepatic lipid deposition in large yellow croaker (Larmichthys crocea).

Authors:  Dongwu Liu; Kangsen Mai; Yanjiao Zhang; Wei Xu; Qinghui Ai
Journal:  Fish Physiol Biochem       Date:  2016-02       Impact factor: 2.794

2.  Mutations in WNT10B Are Identified in Individuals with Oligodontia.

Authors:  Ping Yu; Wenli Yang; Dong Han; Xi Wang; Sen Guo; Jinchen Li; Fang Li; Xiaoxia Zhang; Sing-Wai Wong; Baojing Bai; Yao Liu; Jie Du; Zhong Sheng Sun; Songtao Shi; Hailan Feng; Tao Cai
Journal:  Am J Hum Genet       Date:  2016-06-16       Impact factor: 11.025

3.  Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas.

Authors:  Mara Gilardi; Zhiyong Wang; Marco Proietto; Anastasia Chillà; Juan Luis Calleja-Valera; Yusuke Goto; Marco Vanoni; Matthew R Janes; Zbigniew Mikulski; Antonio Gualberto; Alfredo A Molinolo; Napoleone Ferrara; J Silvio Gutkind; Francis Burrows
Journal:  Mol Cancer Ther       Date:  2020-07-29       Impact factor: 6.261

4.  Strong effect of SNP rs4988300 of the LRP5 gene on bone phenotype of Caucasian postmenopausal women.

Authors:  Péter Horváth; Bernadett Balla; János P Kósa; Bálint Tóbiás; Balázs Szili; Gyöngyi Kirschner; Gabriella Győri; Karina Kató; Péter Lakatos; István Takács
Journal:  J Bone Miner Metab       Date:  2015-03-12       Impact factor: 2.626

5.  Silencing of Wnt10B reduces viability of heptocellular carcinoma HepG2 cells.

Authors:  Guohui Wu; Xiaoli Fan; Li Sun
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

6.  GATA4 regulates mesenchymal stem cells via direct transcriptional regulation of the WNT signalosome.

Authors:  Aysha B Khalid; Jacquelyn Pence; Sarocha Suthon; Jianjian Lin; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  Bone       Date:  2020-12-16       Impact factor: 4.398

7.  WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.

Authors:  Ren-Jun Hsu; Jar-Yi Ho; Tai-Lung Cha; Dah-Shyong Yu; Chieh-Lin Wu; Wei-Ping Huang; Pauling Chu; Ying-Hsin Chen; Jiann-Torng Chen; Cheng-Ping Yu
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

8.  WNT10B Polymorphism in Korean Stroke Patients with Yin Deficiency Pattern.

Authors:  Mi Mi Ko; Tae-Yong Park; Ji Hye Lim; Min Ho Cha; Myeong Soo Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-08       Impact factor: 2.629

9.  WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer.

Authors:  Peter Wend; Stephanie Runke; Korinna Wend; Brenda Anchondo; Maria Yesayan; Meghan Jardon; Natalie Hardie; Christoph Loddenkemper; Ilya Ulasov; Maciej S Lesniak; Rebecca Wolsky; Laurent A Bentolila; Stephen G Grant; David Elashoff; Stephan Lehr; Jean J Latimer; Shikha Bose; Husain Sattar; Susan A Krum; Gustavo A Miranda-Carboni
Journal:  EMBO Mol Med       Date:  2013-01-11       Impact factor: 12.137

10.  FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.

Authors:  Julia Brun; François-Xavier Dieudonné; Caroline Marty; Judith Müller; Roland Schüle; Ana Patiño-García; Fernando Lecanda; Olivia Fromigué; Pierre J Marie
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.